Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Elewski

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2019
Itch: an under-recognized problem in psoriasisB Elewski, A F Alexis, M Lebwohl, et al.
The British Journal of Dermatology|January 4, 2007
Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasisB Elewski, C Leonardi, A B Gottlieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2018
Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trialsA B Gottlieb, K Gordon, S Hsu, et al.
Journal of the American Academy of Dermatology|February 13, 2003
Tinea capitis in Cleveland: survey of elementary school studentsM Ghannoum, N Isham, R Hajjeh, et al.
The British Journal of Dermatology|June 2, 2020
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE studyK Reich, J Sullivan, P Arenberger, et al.
Journal of the American Academy of Dermatology|April 1, 1993
Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimensP R Bergstresser, B Elewski, J Hanifin, et al.
Journal of the American Academy of Dermatology|February 1, 1997
One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trialR Savin, R L De Villez, B Elewski, et al.
Journal of the American Academy of Dermatology|February 1, 1995
Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazoleB Elewski, P R Bergstresser, J Hanifin, et al.
Journal of the American Academy of Dermatology|April 1, 1994
Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multicenter trialsR Savin, A V Atton, P R Bergstresser, et al.
The British Journal of Dermatology|July 8, 2015
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trialsK A Papp, M A Menter, M Abe, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2019
Itch: an under-recognized problem in psoriasisB Elewski, A F Alexis, M Lebwohl, et al.
The British Journal of Dermatology|January 4, 2007
Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasisB Elewski, C Leonardi, A B Gottlieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2018
Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trialsA B Gottlieb, K Gordon, S Hsu, et al.
Journal of the American Academy of Dermatology|February 13, 2003
Tinea capitis in Cleveland: survey of elementary school studentsM Ghannoum, N Isham, R Hajjeh, et al.
The British Journal of Dermatology|June 2, 2020
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE studyK Reich, J Sullivan, P Arenberger, et al.
Journal of the American Academy of Dermatology|April 1, 1993
Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimensP R Bergstresser, B Elewski, J Hanifin, et al.
Journal of the American Academy of Dermatology|February 1, 1997
One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trialR Savin, R L De Villez, B Elewski, et al.
Journal of the American Academy of Dermatology|February 1, 1995
Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazoleB Elewski, P R Bergstresser, J Hanifin, et al.
Journal of the American Academy of Dermatology|April 1, 1994
Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multicenter trialsR Savin, A V Atton, P R Bergstresser, et al.
The British Journal of Dermatology|July 8, 2015
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trialsK A Papp, M A Menter, M Abe, et al.
Pageof 4